Hyundai Bioscience Co. Ltd (048410) — Capital Reinvestment Ratio
Hyundai Bioscience Co. Ltd (048410) has a Capital Reinvestment Ratio of 0.96x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩2.26 Billion) in capital expenditures (₩2.17 Billion). See Hyundai Bioscience Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hyundai Bioscience Co. Ltd Capital Reinvestment Ratio (2008–2024)
This chart tracks Hyundai Bioscience Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Check Hyundai Bioscience Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year Capital Reinvestment Ratio for Hyundai Bioscience Co. Ltd from 2008 to 2024. For live market cap and broader valuation context, see 048410 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | ₩2.26 Billion | ₩2.17 Billion | ▼ -71.4% |
| 2020 | 3.36x | ₩7.50 Billion | ₩25.20 Billion | ▲ +906.0% |
| 2019 | 0.33x | ₩9.18 Billion | ₩3.07 Billion | ▼ -76.3% |
| 2018 | 1.41x | ₩5.01 Billion | ₩7.07 Billion | ▼ -81.0% |
| 2015 | 7.41x | ₩87.36 Million | ₩647.57 Million | ▲ +980.0% |
| 2014 | 0.69x | ₩1.22 Billion | ₩840.18 Million | ▲ +917.4% |
| 2011 | 0.07x | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩10.37 Billion | ₩3.92 Billion | — |